Sirnaomics

Developer of RNA based therapeutics for the treatment of cancer and fibrosis disease

placeGaithersburg, Maryland, United States calendar_todayFounded 2007 groups88 employees language sirnaomics.com

Registered entities

Social engagement

Social engagement: 7.5K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record; lead investors include Rotating Boulder Fund, Yuexiu Group, Walvax.

Investor typeCountShare
Venture capital528%
Private equity422%
Accelerator & incubator16%
Bank & private debt16%
Other / undisclosed739%

Recent activity

26 Jun 2026
Event
Oligonucleotide Drug R&D and Innovation Symposium
13 Jun 2026
Product launch
Polypeptide nanoparticles (PNPs)
Coming soon